INTRAVITREAL DEXAMETHASONE FOR THE TREATMENT OF MACULAR EDEMA SECONDARY TO HYDROXYCHLOROQUINE TOXICITY.

Authors :: Mathai M
Zeleny A
Jacobsen BH
Garfinkel RA
Katira R
Fein JG
Source :: Retinal cases & brief reports [Retin Cases Brief Rep] 2024 May 01; Vol. 18 (3), pp. 346-350. Date of Electronic Publication: 2022 Nov 25.
Publication Year :: 2024
Abstract: Purpose: Cystoid macular edema is a vision-threatening complication infrequently associated with hydroxychloroquine retinal toxicity. There are limited data on the best treatment for this pathology.<br />Methods: A retrospective case series is presented.<br />Results: In this series, we present three cases of cystoid macular edema in patients with diagnosed hydroxychloroquine maculopathy successfully treated with intravitreal dexamethasone implantation.<br />Conclusion: Minimal literature has been published regarding the best management of cystoid macular edema related to hydroxychloroquine toxicity. Our case series suggests a possible new agent in the treatment of this rare occurrence.<br /> (Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the Opthalmic Communications Society, Inc.)

Subjects :: Humans
Female
Retrospective Studies
Middle Aged
Male
Aged
Tomography, Optical Coherence
Visual Acuity
Macular Edema drug therapy
Macular Edema chemically induced
Hydroxychloroquine adverse effects
Hydroxychloroquine administration & dosage
Dexamethasone administration & dosage
Dexamethasone therapeutic use
Intravitreal Injections
Glucocorticoids administration & dosage
Antirheumatic Agents adverse effects
Antirheumatic Agents administration & dosage

Full Text Access

Tools